Cybin Inc

NYSE MKT: CYBN
$10.78
-$0.62 (-5.4%)
Closing Price on November 8, 2024

CYBN Stock Chart and Intraday Price

CYBN Stock Data

Asset Type Stock
Exchange NYSE MKT
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address 100 KING STREET WEST, SUITE 5600, TORONTO, ON, CA
Fiscal Year End March
Latest Quarter 12/31/2023
Market Cap 140.71M USD
Shares Outstanding 410,855,000
Cybin Inc is a trailblazer in the biopharmaceutical industry, focusing on the development of psychedelic-based treatments. With a robust pipeline, including CYB003 for major depressive and alcohol use disorders, CYB004 for generalized anxiety, and CYB005 for neuroinflammation, Cybin is at the forefront of exploring the therapeutic potential of psychedelics. Additionally, its EMBARK model offers a unique psychological support framework, enhancing the healing process. Based in Toronto, Canada, Cybin is committed to unlocking new pathways to mental wellness.

CYBN Articles

6 Popular Penny Stocks on Robinhood - Are They Good Investments?
Penny stocks have become a popular thing to put a couple of bucks into and see what happens. Worst case scenario, you’re not out a lot of money. Best case scenario, you make a killing and don’t...
Andrew Dupont
Published:

5 Psychedelic Therapeutics Decisions Coming in 2022
Here is a look of a few of the biggest clinical trial and FDA updates in regards to psychedelics to watch for in 2022.
Chris Lange
Published:

Time to Buy the Magic Stocks? Magic Mushrooms, That Is.
Here's a quick look at six publicly traded companies developing ways to use psychedelics to treat mental health issues.
Paul Ausick
Published: